Log In
Print this Print this

Gentamicin Surgical Implant

Also known as: CollaRx gentamicin surgical implant

  Manage Alerts
Collapse Summary General Information
Company Innocoll Holdings plc
DescriptionGentamicin surgical implant developed using CollaRx sponge membrane technology
Molecular Target Ribosomal 30S subunit
Mechanism of ActionRibosomal 30S subunit inhibitor
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentMarketed
Standard IndicationBacterial infection
Indication DetailsAs an adjunct to prevent surgical site infections; Prevent surgical site infections; Treat mildly infected diabetic foot ulcers
Regulatory Designation U.S. - Fast Track (Prevent surgical site infections)
PartnerBaxter International Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today